Evidence map›Paper›PMID 35460492›Full record

ReviewCurrent pain and headache reports2022

Patients on Buprenorphine Formulations Undergoing Surgery.

Katelynn Champagne, Preshita Date, Juan Pablo Forero, Joshua Arany, Karina Gritsenko

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katelynn ChampagneDepartment of Anesthesiology, Montefiore Medical Center, 111 East 210th St, Bronx, NY, 10467, USA.
Preshita DateDepartment of Anesthesiology, Montefiore Medical Center, 111 East 210th St, Bronx, NY, 10467, USA.
Juan Pablo ForeroAlbert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY, 10461, USA.
Joshua AranyTownsend Harris High School, 149-11 Melbourne Ave, Flushing, NY, 11367, USA.
Karina GritsenkoDepartment of Anesthesiology, Montefiore Medical Center, 111 East 210th St, Bronx, NY, 10467, USA. kgritsen@montefiore.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo review the pharmacology of buprenorphine, the evolution of buprenorphine dosing recommendations, and the current literature regarding its recommendations for the perioperative period. RECENT

findingsThere is a consensus that for all surgeries, buprenorphine should be continued throughout the perioperative period. If the surgery is a minimal to mild pain surgery, no dose adjustment is needed. There is no clear consensus regarding moderate to severe pain. With all surgeries, multimodal analgesia should be utilized, with regional anesthesia when possible. Patients taking buprenorphine should continue their buprenorphine perioperatively; whether to decrease or maintain dosing is up for debate. Multimodal analgesia should also be used throughout the perioperative period, and communication between the patient and all provider teams is of the utmost importance to provide adequate analgesia during the perioperative period, as well as to arrange safe analgesia upon discharge.

Indexed as

AnalgesiaBuprenorphineAnalgesics, OpioidHumansPainPain ManagementPostoperative PainAnalgesics, OpioidBuprenorphineBuprenorphineBuprenorphine pharmacologyMultimodal analgesiaPerioperative buprenorphinePre-operative buprenorphine, Post-operative buprenorphine

Identifiers

PMID35460492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.